Chronic relapsing experimental allergic encephalomyelitis: morphological sequence of myelin degradation.

Chronic experimental allergic encephalomyelitis.

T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis.

Myelin basic protein treatment of experimental allergic encephalomyelitis in monkeys.

Peripheral nervous system pathology in relapsing experimental allergic encephalomyelitis.

Chronic relapsing experimental allergic encephalomyelitis: CNS plaque development in unsuppressed and suppressed animals.

Chronic relapsing experimental allergic encephalomyelitis. Correlation of circulating lymphocyte fluctuations with disease activity in suppressed and unsuppressed animals.

Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis.

Progressive demyelination and reparative phenomena in chronic experimental allergic encephalomyelitis.

Fenestrated CNS blood vessels in chronic experimental allergic encephalomyelitis.

Active inflammation increases the heterogeneity of MRI texture in mice with relapsing experimental allergic encephalomyelitis.

Hyperphenylalaninaemia and experimental allergic encephalomyelitis.

Cell-mediated immunity to myelin basic protein in Lewis rats made unresponsive to experimental allergic encephalomyelitis.

Cellular immune crossreactivity between myelin basic protein and synapsin in rats with experimental allergic encephalomyelitis.

Alkyllysophospholipid prevents induction of experimental allergic encephalomyelitis.

Modulation of experimental allergic encephalomyelitis by somatostatin.

Experimental allergic encephalomyelitis in aged F344 rats.

The T lymphocyte in experimental allergic encephalomyelitis.

Cerebrospinal fluid lymphocytes in experimental allergic encephalomyelitis.

Multiple Sclerosis and Experimental Allergic Encephalomyelitis.

Sympathectomy augments adoptively transferred experimental allergic encephalomyelitis.

Early myelin lesions in experimental allergic neuritis.

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.

Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.

The distribution of myelin basic protein in central nervous system lesions of multiple sclerosis and acute experimental allergic encephalomyelitis.

Suggest Documents

Chronic experimental allergic encephalomyelitis.

T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis.

Myelin basic protein treatment of experimental allergic encephalomyelitis in monkeys.

Peripheral nervous system pathology in relapsing experimental allergic encephalomyelitis.

Chronic relapsing experimental allergic encephalomyelitis: CNS plaque development in unsuppressed and suppressed animals.

Chronic relapsing experimental allergic encephalomyelitis. Correlation of circulating lymphocyte fluctuations with disease activity in suppressed and unsuppressed animals.

Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis.

Progressive demyelination and reparative phenomena in chronic experimental allergic encephalomyelitis.

Fenestrated CNS blood vessels in chronic experimental allergic encephalomyelitis.

Active inflammation increases the heterogeneity of MRI texture in mice with relapsing experimental allergic encephalomyelitis.

Hyperphenylalaninaemia and experimental allergic encephalomyelitis.

Cell-mediated immunity to myelin basic protein in Lewis rats made unresponsive to experimental allergic encephalomyelitis.

Cellular immune crossreactivity between myelin basic protein and synapsin in rats with experimental allergic encephalomyelitis.

Alkyllysophospholipid prevents induction of experimental allergic encephalomyelitis.

Modulation of experimental allergic encephalomyelitis by somatostatin.

Experimental allergic encephalomyelitis in aged F344 rats.

The T lymphocyte in experimental allergic encephalomyelitis.

Cerebrospinal fluid lymphocytes in experimental allergic encephalomyelitis.

Multiple Sclerosis and Experimental Allergic Encephalomyelitis.

Sympathectomy augments adoptively transferred experimental allergic encephalomyelitis.

Early myelin lesions in experimental allergic neuritis.

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.

Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.

The distribution of myelin basic protein in central nervous system lesions of multiple sclerosis and acute experimental allergic encephalomyelitis.

Chronic relapsing experimental allergic encephalomyelitis: morphological sequence of myelin degradation.

Recommend Documents

Follow Us